Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.936
-0.042 (-2.12%)
Sep 2, 2026, 5:29 PM CET
Medivir AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.4 | 119.21 | 62.53 | 169.52 | 117.43 | 221.17 |
Cash & Short-Term Investments | 253.5 | 119.21 | 62.53 | 169.52 | 117.43 | 221.17 |
Cash Growth | 563.61% | 90.65% | -63.11% | 44.35% | -46.90% | 215.92% |
Accounts Receivable | 5.5 | 0.5 | 0.59 | 4.45 | 1.2 | 0.83 |
Other Receivables | - | 3.46 | 2.8 | 4.21 | 3.67 | 3.17 |
Receivables | 5.5 | 3.96 | 3.39 | 8.66 | 4.88 | 3.99 |
Prepaid Expenses | - | 0.59 | 0.73 | 1.06 | 0.73 | 0.76 |
Other Current Assets | - | - | - | - | 0 | - |
Total Current Assets | 259 | 123.76 | 66.65 | 179.24 | 123.04 | 225.92 |
Property, Plant & Equipment | 5.7 | 6.95 | 9.64 | 12.36 | 14.84 | 13.6 |
Long-Term Deferred Charges | 66.5 | 66.49 | 96.31 | 96.31 | 96.31 | 96.31 |
Other Long-Term Assets | - | - | -0 | 0 | -0 | -0 |
Total Assets | 331.2 | 197.19 | 172.59 | 287.91 | 234.2 | 335.83 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 6.28 | 12.07 | 16.36 | 3.76 | 10.34 |
Accrued Expenses | - | 4.83 | 17.74 | 17.09 | 6.52 | 10.39 |
Current Portion of Leases | - | 2.61 | 2.46 | 2.27 | 2.11 | 1.05 |
Other Current Liabilities | 30.5 | 20.1 | 16.2 | 23.01 | 15.62 | 19.93 |
Total Current Liabilities | 30.5 | 33.81 | 48.47 | 58.72 | 28.01 | 41.72 |
Long-Term Leases | 4.5 | 5.78 | 8.61 | 11.26 | 13.4 | 12.96 |
Other Long-Term Liabilities | 0.4 | 2.39 | -0 | -0 | - | -0 |
Total Liabilities | 35.4 | 41.98 | 57.07 | 69.99 | 41.41 | 54.68 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 93.1 | 67.67 | 57.31 | 52.69 | 27.87 | 27.87 |
Additional Paid-In Capital | 1,212 | 1,067 | 926.02 | 910.27 | 805.35 | 804.94 |
Retained Earnings | -1,006 | -976.23 | -864.5 | -741.72 | -637.18 | -548.42 |
Comprehensive Income & Other | -3.3 | -3.31 | -3.31 | -3.31 | -3.24 | -3.25 |
Shareholders' Equity | 295.8 | 155.22 | 115.52 | 217.93 | 192.79 | 281.15 |
Total Liabilities & Equity | 331.2 | 197.19 | 172.59 | 287.91 | 234.2 | 335.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.5 | 8.39 | 11.07 | 13.54 | 15.51 | 14.02 |
Net Cash (Debt) | 249 | 110.82 | 51.46 | 155.98 | 101.92 | 207.15 |
Net Cash Growth | 708.44% | 115.36% | -67.01% | 53.04% | -50.80% | 287.06% |
Net Cash Per Share | 0.72 | 0.78 | 0.45 | 2.58 | 1.83 | 3.92 |
Filing Date Shares Outstanding | 617.94 | 448.67 | 112.17 | 104.49 | 55.72 | 55.72 |
Total Common Shares Outstanding | 617.94 | 448.67 | 112.17 | 104.49 | 55.72 | 55.72 |
Working Capital | 228.5 | 89.95 | 18.18 | 120.51 | 95.04 | 184.2 |
Book Value Per Share | 0.48 | 0.35 | 1.03 | 2.09 | 3.46 | 5.05 |
Tangible Book Value | 295.8 | 155.22 | 115.52 | 217.93 | 192.79 | 281.15 |
Tangible Book Value Per Share | 0.48 | 0.35 | 1.03 | 2.09 | 3.46 | 5.05 |
Buildings | - | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 |
Machinery | - | - | 4.29 | 4.29 | 4.29 | 3.9 |